<i>Tribulus terrestris</i>-Mediated ZnO/Ag-Halloysite Nanohybrids for Targeted Cisplatin and Carboplatin Delivery in Cervical Cancer Treatment. [PDF]
AlAbdullatif A +5 more
europepmc +1 more source
Nanotechnology in Skin Cancer Therapy: Recent Progress in Targeted Delivery. [PDF]
Yu HP, Hsu CY, Fang JY, Lin ZC.
europepmc +1 more source
Clavanin bacterial sepsis control using a novel methacrylate nanocarrier. [PDF]
ARAUJO, A. C. G. +9 more
core
Advancing Photodynamic Cancer Therapy with Smart Light-Responsive Lipid and Polymeric Nanocarriers: Evidence from a Meta-Analysis of Efficacy and Pharmacokinetics. [PDF]
Agiba AM +6 more
europepmc +1 more source
pH-Sensitive Naproxen Delivery via ZIF and Kaolin@ZIF Nanocarriers in 3D-Printed PLA-Gelatin Hydrogels. [PDF]
Çetin R, Ates B, Gok O, Benli B.
europepmc +1 more source
Corrigendum: Nanocarrier-mediated RNAi of <i>CYP9E2</i> and <i>CYB5R</i> enhance susceptibility of invasive tomato pest, <i>Tuta absoluta</i> to cyantraniliprole. [PDF]
Ullah F +9 more
europepmc +1 more source
RETRACTION: Preparation of a pH-Responsive Chitosan-Montmorillonite-Nitrogen-Doped Carbon Quantum Dots Nanocarrier for Attenuating Doxorubicin Limitations in Cancer Therapy. [PDF]
europepmc +1 more source
Related searches:
An approach to the design and fabrication of mechanized mesoporous silica nanoparticles is demonstrated at the proof of principle level. It relies on the reductive cleavage of disulfide bonds within an integrated nanosystem, wherein surface-bound rotaxanes incorporate disulfide bonds in their stalks, which are encircled by cucurbit[6]uril or alpha ...
Ambrogio, Michael W. +8 more
openaire +3 more sources
With the rapid development of nanoparticles in drug delivery system, a lot of interest in the genotoxicity evaluation of nanocarriers has emerged currently. Here our emphasis was placed on the summary of studies on standard genotoxicity assays.We performed a PubMed/MEDLINE search for all publications in the English language related to assessment of ...
Ting, Luo +4 more
openaire +2 more sources

